Abstract
Objective
The objective of this study was to identify, document, and weight attributes of a pain medication that are relevant from the perspective of patients with chronic pain. Within the sub-population of patients suffering from “chronic neuropathic pain”, three groups were analyzed in depth: patients with neuropathic back pain, patients with painful diabetic polyneuropathy, and patients suffering from pain due to post-herpetic neuralgia. The central question was: “On which features do patients base their assessment of pain medications and which features are most useful in the process of evaluating and selecting possible therapies?”
Methods
A detailed literature review, focus groups with patients, and face-to-face interviews with widely recognized experts for pain treatment were conducted to identify relevant treatment attributes of a pain medication. A pre-test was conducted to verify the structure of relevant and dominant attributes using factor analyses by evaluating the most frequently mentioned representatives of each factor. The Discrete-Choice Experiment (DCE) used a survey based on self-reported patient data including socio-demographics and specific parameters concerning pain treatment. Furthermore, the neuropathic pain component was determined in all patients based on their scoring in the painDETECT® questionnaire. For statistical data analysis of the DCE, a random effect logit model was used and coefficients were presented.
Results
A total of 1,324 German patients participated in the survey, of whom 44 % suffered from neuropathic back pain (including mixed pain syndrome), 10 % complained about diabetic polyneuropathy, and 4 % reported pain due to post-herpetic neuralgia. A total of 36 single quality aspects of pain treatment, detected in the qualitative survey, were grouped in 7 dimensions by factor analysis. These 7 dimensions were used as attributes for the DCE. The DCE model resulted in the following ranking of relevant attributes for treatment decision: “no character change”, “less nausea and vomiting”, “pain reduction” (coefficient: >0.9 for all attributes, “high impact”), “rapid effect”, “low risk of addiction” (coefficient ~0.5, “middle impact”), “applicability with comorbidity” (coefficient ~0.3), and “improvement of quality of sleep” (coefficient ~0.25). All attributes were highly significant (p < 0.001).
Conclusions
The results were intended to enable early selection of an individualized pain medication. The results of the study showed that DCE is an appropriate means for the identification of patient preferences when being treated with specific pain medications. Due to the fact that pain perception is subjective in nature, the identification of patients´ preferences will enable therapists to better develop and implement patient-oriented treatment of chronic pain. It is therefore essential to improve the therapists´ understanding of patient preferences in order to make decisions concerning pain treatment. DCE and direct assessment should become valid instruments to elicit treatment preferences in chronic pain.
Similar content being viewed by others
References
Alvaro, M., Kumar, D., Julka, I.S.: Transcutaneous electrostimulation: emerging treatment for diabetic neuropathic pain. Diabetes Technol. Ther. 1, 77–80 (1999)
Argoff, C.E.: The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin. J. Pain 23, 15–22 (2007)
Baron, R.: Diagnostik und Therapie neuropathischer Schmerzen. Dtsch. Arztebl. 103, 2720–2730 (2006)
Barrett, A.M., Lucero, M.A., Le, T., et al.: Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 8, S50–S62 (2007)
Bas, H.: Pharmakotherapie bei neuropathischen Schmerzen durch Nichtspezialisten—Neue NICE-Leitlinien. ARS MEDICI 13, 540–542 (2010)
Ben-Akiva, M., Lerman, S.R.: Discrete Choice Analysis: Theory and Application to Travel Demand. MIT Press, Cambridge (1985)
Bennett, M.I., Attal, N., Backonja, M.M., et al.: Using screening tools to identify neuropathic pain. Pain 127, 199–203 (2007)
Bowling, A., Ebrahim, S.: Measuring patients’ preferences for treatment and perceptions of risk. Qual. Health Care 10, i2–i8 (2001)
Bradley, M.: User’s manual for the speed version 2.1 stated preference version 2.1 stated preference experiment editor and designer. Hague Consulting Group, The Hague (1991)
Breivik, H., Collett, B., Ventafridda, V., et al.: Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 10, 287 (2006)
Bridges, J., Hauber, A., Marshall, D. et al.: Checklist for conjoint analysis applications in health: report of the ISPOR conjoint analysis good Research practices Taskforce, in press (2009)
Bridges, J., Hauber, B., Marshall, D., et al.: Conjoint analysis use in health studies—a checklist: a report of the ISPOR conjoint analysis in health good research practices task force. In: ISPOR TF Report. Baltimore (2011)
Bridges, J., Onukwugha, E., Johnson, F., et al.: Patient preference methods—a patient centered evaluation paradigm. ISPOR Connect. 13, 4–7 (2007)
Bridges, J.F., Kinter, E.T., Kidane, L., et al.: Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982–2007. Patient 14, 273–282 (2008)
Bridges, J.F., Slawik, L., Schmeding, A., et al.: A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia. Health Expect. 16, 164–176 (2011)
Bryan, S., Gold, L., Sheldon, R., et al.: Preference measurement using conjoint methods: an empirical investigation of reliability. Health Econ. 9, 385–395 (2000)
Bryan, S., Parry, D.: Structural reliability of conjoint measurement in health care: an empirical investigation. Appl. Econ. 34, 561–568 (2002)
Burgess, L.: Discrete choice experiments (computer software). In: Department of Mathematical Sciences, University of Technology, Sydney (2007)
Carroll, D., Moore, R., Mcquay, H., et al.: Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Libr. (2002)
Crooks, L.K.: Assessing pain and the Joint Commission pain standards. Adv. Emerg. Nurs. J. 24, 1–9 (2002)
De Bekker-Grob, E.W., Ryan, M., Gerard, K.: Discrete choice experiments in health economics: a review of the literature. Health Econ. 21, 145–172 (2012)
Diener, H.C., Putzki, N., Berlit, P.: Leitlinien für Diagnostik und Therapie in der Neurologie Thieme Stuttgart (2008)
Ducharme, J.: Acute pain and pain control: state of the art. Ann. Emerg. Med. 35, 592–603 (2000)
Dworkin, R.H., Johnson, R.W., Breuer, J., et al.: Recommendations for the management of herpes zoster. Clin. Infect. Dis. 44, S1–S26 (2007)
Edwards, A., Elwyn, G.: Inside the black box of shared decision making: distinguishing between the process of involvement and who makes the decision. Health Expect. 9, 307–320 (2006)
Edwards, A., Elwyn, G., Wood, F., et al.: Shared decision making and risk communication in practice: a qualitative study of GPs’ experiences. Br. J. Gen. Pract. 55, 6 (2005)
Fleming, D., Cross, K., Cobb, W., et al.: Gender difference in the incidence of shingles. Epidemiol. Infect. 132, 1–5 (2004)
Flynn, T.N., Louviere, J.J., Peters, T.J., et al.: Best–worst scaling: what it can do for health care research and how to do it. J. Health Econ. 26, 171–189 (2007)
Flynn, T.N., Louviere, J.J., Peters, T.J., et al.: Estimating preferences for a dermatology consultation using Best-Worst Scaling: comparison of various methods of analysis. BMC Med. Res. Methodol. 8, 76 (2008)
Freynhagen, R., Baron, R., Gockel, U., et al.: Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Current Med. Res. Opin. 22, 1911–1920 (2006)
Freynhagen, R., Busche, P., Konrad, C., et al.: Wirksamkeit und Wirkungsbeginn von Pregabalin bei Patienten mit neuropathischen Schmerzen. Der Schmerz 20, 285–292 (2006)
Freynhagen, R., Tölle, T., Gockel, U., et al.: PainDETECT-ein Palmtop-basiertes Verfahren für Versorgungsforschung, Qualitätsmanagement und Screening bei chronischen Schmerzen. Aktuelle Neurologie 32, P641 (2005)
Fricker, J.: Pain in Europe. A report. The Pain Society, Cambridge (2003)
Gore, M., Brandenburg, N.A., Hoffman, D.L., et al.: Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J. Pain 7, 892 (2006)
Haanpää, M., Treede, F.: Diagnosis and classification of neuropathic pain. IASP Clin. Updates 18, 1–6 (2010)
Hauber, A.B.: Healthy-years equivalent: wounded but not yet dead. Expert Rev. Pharmacoecon. Outcomes Res. 9, 265–270 (2009)
Hensher, D., Rose, J., Greene, W.: Applied choice Analysis: a Primer. Cambridge University Press, Cambridge (2005)
Huber, J., Zwerina, K.: The importance of utility balance in efficient choice designs. J. Mark. Res. 33, 307–317 (1996)
Icks, A., Rathmann, W., Rosenbauer, J., et al.: Gesundheitsberichterstattung des Bundes, Heft 24: Diabetes mellitus. Robert Koch-Institut (2007)
Insinga, R.P., Itzler, R.F., Pellissier, J.M., et al.: The incidence of herpes zoster in a United States administrative database. J. Gen. Intern. Med. 20, 748–753 (2005)
Iskedjian, M., Einarson, T., Walker, J. H., et al.: Anticonvulsants, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants in management of neuropathic pain: a meta-analysis and economic evaluation (Technology report). In: Canadian Agency for Drugs and Technologies in Health, Ottawa (2009)
Jensen, T.S., Backonja, M.-M., Jiménez, S.H., et al.: New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes Vas. Dis. Res. 3, 108–119 (2006)
Johnson, F.R., Banzhaf, M.R., Desvousges, W.H.: Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach. Health Econ. 9, 295–317 (2000)
Johnson, F.R., Hauber, A.B., Özdemir, S.: Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to Vasomotor symptoms. Value Health 12, 146–152 (2009)
Johnson, F.R., Ozdemir, S., Mansfield, C., et al.: Crohn’s disease patients’ risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology 133, 769–779 (2007)
Junker, U., Baron, R., Freynhagen, R.: Das “mixed pain concept“ als neue Rationale. Das Zusammenspiel von nozizeptiven und neuropathischen Schmerzen erfordert die neuen Wege der Analgesie. Dtsch Arztebl 101, A1393–A1394 (2004)
Kleinman, L., Mcintosh, E., Ryan, M., et al.: Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch. Intern. Med. 162, 1361–1366 (2002)
Lancaster, K.: Consumer Demand: A New Approach. Columbia University Press, New York (1971)
Lancaster, K.J.: A New Approach to Consumer Theory. Bobbs-Merrill, Indianapolis (1966)
Lancaster, K.J.: A new approach to consumer theory. J. Polit. Econ. 74, 132–157 (1966)
Lancsar, E., Louviere, J.: Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics 26, 661–678 (2008)
Lancsar, E., Louviere, J., Flynn, T.: Several methods to investigate relative attribute impact in stated preference experiments. Soc. Sci. Med. 64, 1738–1753 (2007)
Langley, P.C.: The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costs. J. Med. Econ. 15, 1201–1215 (2012)
Loh, A., Simon, D., Bieber, C., et al.: Patient and citizen participation in German health care-current state and future perspectives. Zeitschrift für ärztliche Fortbildung und Qualität im Gesundheitswesen-German J. Qual. Health Care 101, 229–235 (2007)
Louviere, J.J., Hensher, D.A., Swait, J.D.: Stated Choice Methods: Analysis and Application. Cambridge University Press, Cambridge (2000)
Louviere, J.J., Hensher, D.A., Swait, J.D.: Stated choice methods: analysis and applications. Cambridge University Press, Cambridge (2000)
Louviere, J.J., Lancsar, E.: Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Health Econ. Policy Law 4, 527–546 (2009)
Mcdermott, A.M., Toelle, T.R., Rowbotham, D.J., et al.: The burden of neuropathic pain: results from a cross-sectional survey. Eur. J. Pain 10, 127 (2006)
Mcfadden, D.: Conditional logit analysis of qualitative choice behavior. in Frontiers of Econometrics, ed. by P. Zarembka, Academic Press, New York, pp. 105–142 (1973)
Meyer-Rosberg, K., Burckhardt, C.S., Huizar, K., et al.: A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur. J. Pain 5, 391–403 (2001)
Morgan, A., Shackley, P., Pickin, M., et al.: Quantifying patient preferences for out-of-hours primary care. J. Health Serv. Res. Policy 5, 214–218 (2000)
Moulin, D., Clark, A., Gilron, I., et al.: Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Research & Management: The Journal of the Canadian Pain Society 12, 13 (2007)
Mühlbacher, A., Juhnke, C.: Patients preferences versus physicians judgments: does it make a difference in health care decision-making? Appl. Health Econ. Health Policy 11, 163–180 (2013)
Mühlbacher, A., Juhnke, C., Bethge, S.: Experts’ judgment on patient-centered coordinated care. Value Health 13, A337 (2010)
Mühlbacher, A., Lincke, H., Nübling, M.: Evaluating patients’ preferences for multiple myeloma therapy, a discrete choice experiment. GMS Psycho-Social-Med. 5 (2008)
Mühlbacher, A.C., Bethge, S., Tockhorn, A.: Präferenzmessung im Gesundheitswesen: grundlagen von Discrete-Choice-Experimenten. Gesundheitsökonomie Qualitätsmanagement 1, 17–44 (2013)
Mühlbacher, A.C., Stoll, M., Mahlich, J., et al.: Patient preferences for HIV/AIDS therapy-a discrete choice experiment. Health Econ. Rev. 3, 1–8 (2013)
Neuhauser, H., Ellert, U., Ziese, T.: Chronische Rückenschmerzen in der Allgemeinbevölkerung in Deutschland 2002/2003: prävalenz und besonders betroffene Bevölkerungsgruppen. Das Gesundheitswesen 67, 685–693 (2005)
Nice Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. Clinical guideline 96. In: National Institute for Health and Clinical Excellence London (2010)
Ohayon, M.M., Stingl, J.C.: Prevalence and comorbidity of chronic pain in the German general population. J. Psychiatr. Res. 46, 444–450 (2012)
Orme, B. Sample size issues for conjoint analysis studies. Sawthooth Software Research paper Series. Squim, WA, USA: Sawthooth Software Inc (1998)
Phillips, K.A., Johnson, F.R., Maddala, T.: Measuring what people value: a comparison of “attitude” and “preference” surveys. Health Serv. Res. 37, 1659–1679 (2002)
Pittler, M.H., Ernst, E.: Complementary therapies for neuropathic and neuralgic pain: systematic review. Clin. J. Pain 24, 731–733 (2008)
Poliakov, I., Toth, C.: The impact of pain in patients with polyneuropathy. Eur. J. Pain 15, 1015–1022 (2011)
Ryan, M., Bate, A., Eastmond, C.J., et al.: Use of discrete choice experiments to elicit preferences. Qual. Health Care 10(Suppl 1), i55–i60 (2001)
Ryan, M., Farrar, S.: Eliciting preference for healthcare using conjoint analysis. BMJ. 320, 1530–1533 (2000)
Ryan, M., Farrar, S.: Using conjoint analysis to elicit preferences for health care. BMJ (Clinical research ed) 320, 1530–1533 (2000)
Ryan, M., Gerard, K.: Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl. Health Econ. Health Policy 2, 55–64 (2003)
Ryan, M., Gerard, K., Amaya-Amaya, M.: Using discrete choice experiments to value health and health care. Springer, Dordrecht (2008)
Ryan, M., Hughes, J.: Using conjoint analysis to assess women’s preferences for miscarriage management. Health Econ. 6, 261–273 (1997)
Sachverständigenrat Für Die Konzertierte Aktion Im Gesundheitswesen (Svr) Gutachten 2000/2001: Bedarfsgerechtigkeit und Wirtschaftlichkeit. Band III. Über-, Unter- und Fehlversorgung. In:BT-Drucksache 14/6871 vom 31. 08. 2001 (2001)
Schmader, K., Gnann, J.W., Watson, C.P.: The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J. Infect. Dis. 197, S207–S215 (2008)
Schmader, K.E.: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain 18, 350–354 (2002)
Scott, A., Vick, S.: Patients, doctors and contracts: an application of principal-agent theory to the doctor-patient relationship. Scottish J. Polit. Econ. 46, 111–134 (1999)
Siegel, E.: Versorgungsstrukturen, Berufsbilder und professionelle Diabetesorganisationen in Deutschland. Deutscher Gesundheitsbericht Diabetes 2011, 23–33 (2010)
Street, D.J., Burgess, L.: The construction of optimal stated choice experiments: theory and methods. Wiley, London (2007)
Tan, T., Barry, P., Reken, S., et al.: Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance. BMJ 340, c1079 (2010)
Telser, H.: Nutzenmessung im Gesundheitswesen: die Methode der Discrete-Choice-Experimente. Dr. Kovač, Hamburg (2002)
Telser, H.B.K., Zweifel, P.: Validity and reliability of willingness-to-pay estimates: evidence from two overlapping discrete-choice-experiments. Patient, Patient-Cent. Outcome Res. 1, 283–293 (2008)
Telser, H., Zweifel, P.: Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. Health Econ. 11, 129–139 (2002)
Thurstone LL: A law of comparative judgment. In Maranell GM (ed): Scaling: A Sourcebook for Behavioral Scientists. Chicago, IL, Aldine, pp 81–92 (1974)
Torrance, N., Smith, B.H., Bennett, M.I., et al.: The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J. Pain 7, 281–289 (2006)
Train, K.: Discrete Choice Methods with Simulation. Cambridge University Press, Cambridge (2009)
Trope, Y., Liberman, N.: Construal-level theory of psychological distance. Psychol. Rev. 117, 440 (2010)
Trope, Y., Liberman, N., Wakslak, C.: Construal levels and psychological distance: effects on representation, prediction, evaluation, and behavior. J. Consum. Psychol 17, 83 (2007)
Ubach, C., Scott, A., French, F., et al.: What do hospital consultants value about their jobs?A discrete choice experiment. BMJ 326, 1432 (2003)
Vázquez, M., Shapiro, E.D.: Varicella vaccine and infection with varicella–zoster virus. N. Engl. J. Med. 352, 439–440 (2005)
Veves, A., Backonja, M., Malik, R.A.: Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 9, 660–674 (2008)
Vick, S., Scott, A.: Agency in health care. Examining patients’ preferences for attributes of the doctor-patient relationship. J. Health Econ. 17, 587–605 (1998)
Wong, M.-C., Chung, J.W., Wong, T.K.: Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 335, 87 (2007)
Ziegler, D.: Painful diabetic neuropathy: treatment and future aspects. Diabetes/metabolism Res. Rev 24, S52–S57 (2008)
Zussman, J., Young, L.: Zoster vaccine live for the prevention of shingles in the elderly patient. Clin. Interv. Aging 3, 241 (2008)
Acknowledgements
The authors extend their thanks to the patient advocacy group “Deutsche Schmerzliga e.V.” for their support in conducting this study. The authors benefited from the valuable assistance of Susanne Bethge (IGM Institute Health Economics and Healthcare Management, Hochschule Neubrandenburg). This research was financed with support from Pfizer Deutschland GmbH, Berlin, Germany.
Conflict of interest
The authors have no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mühlbacher, A.C., Junker, U., Juhnke, C. et al. Chronic pain patients’ treatment preferences: a discrete-choice experiment. Eur J Health Econ 16, 613–628 (2015). https://doi.org/10.1007/s10198-014-0614-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-014-0614-4